Company: CERO
Filing Date: 2025-06-11
Form Type: 8-K
Source: 0001213900-25-053292
Chunk: 1

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-06-11
Form: 8-K
Item: Item 8.01
Chunk 1
---
 predict all such risk
factors, nor can the Company assess the impact of all such risk factors on its business, or the extent to which any factor or combination
of factors may cause actual results to differ materially from those contained in any forward-looking statements. Forward-looking statements
are not guarantees of performance. You should not put undue reliance on these statements, which speak only as of the date hereof. All
forward-looking statements made by the Company or persons acting on its behalf are expressly qualified in their entirety by the foregoing
cautionary statements. The Company undertakes no obligation to update or revise publicly any forward-looking statements, whether as a
result of new information, future events or otherwise, except as required by law.

Item 9.01.
Financial Statements and Exhibits.

(d)
Exhibits.

  Exhibit      Description                                                                                                                   
      No.                                                                                                                                    
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
      3.1      Certificate of Amendment to the Second Amended and Restated Certificate of Incorporation of CERo Therapeutics Holdings, Inc.  
     99.1      Press release, dated June 11, 2025.                                                                                           
      104      Cover Page Interactive Data File (Embedded within the Inline XBRL Document).                                                  

SIGNATURES

Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.

  Date: June 11, 2025      CERO THERAPEUTICS HOLDINGS, INC.                               
 ──────────────────────────────────────────────────────────────────────────────────────────
                           By:                                   /s/ Chris Ehrlich        
                           Name:                                 Chris Ehrlich            
                           Title:                                Chief Executive Officer